Published in Telemedicine Law Weekly, May 5th, 2007
"However, their capacity to identify patients with type 2 DM with nonobstructive subclinical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.